Bill Stilley is featured on Sinclair Broadcasting’s Sunday network feature program “Happening in Health” discussing the future of drug development with Liz Bonis of WKRC in Cincinnati.
FOX31 Denver interviews Bill Stilley, Adial Pharmaceuticals CEO, on the Alcohol Pandemic and Drunk Driving Over the Holidays
Adial Pharmaceutical’s Chief Medical Officer Dr. Bankole Johnson Featured on NBC West Palm Beach, Florida Affiliate
William Stilley, CEO of Adial Pharmaceuticals (NASDAQ: ADIL) sits down with BAF host Michelle Griego to discuss the company’s lead asset, AD04, as a potential genetically targeted treatment for alcohol and opioid use disorder.
William Stilley, President and Chief Executive Officer, on the KSWB-TV FOX 5 Morning News in San Diego to discussing AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder
Adial’s Dr. Bankole Johnson Featured on The Doctors Channel discussing medicinal approaches to alcohol use disorder.
Alcoholism: Is there a medicinal solution on the horizon? EHealth Radio invited Adial’s CEO, William Stilley, for an interview. Listen to the interview to learn more!
Treating Addiction Through Neuroscience Breakthroughs, with Prof. Bankole Johnson of the University of Maryland School of Medicine | EDB 72
Leading internet business program CEO Money Interviews Adial CEO. Adial Pharmaceuticals is developing a genetically targeted treatment for alcohol addiction.
AUTHORITY MAGAZINE, ‘HEROES OF THE ADDICTION CRISIS: HOW WIILLIAM “BILL” STILLEY OF ADIAL PHARMACEUTICALS IS HELPING TO BATTLE ONE OF OUR MOST SERIOUS EPIDEMICS’
Adial Pharmaceuticals Engages CRO to Begin Phase 3 Clinical Trials of AD04 for the Treatment of Alcohol Use Disorder
